Bicara Therapeutics Inc. Common Stock

BCAX | NASDAQ

$22.01

-$0.63 (-2.78%)

At close: Sep 21, 2026, 4:00 PM ET

$22.01

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Net Income	-137.95M	-68M	-51.99M	-37.85M
Depreciation & Amortization	406K	56K	19K	10K
Stock-Based Compensation	15.01M	7.4M	1.9M	810K
Other Working Capital	14.81M	-16.77M	-9.62M	4.95M
Other Non-Cash Items	895K	-77K	14.06M	810K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	14.81M	-14.13M	-9.62M	4.95M
Operating Cash Flow	-106.83M	-74.75M	-45.63M	-32.08M
Capital Expenditures	-280K	-71K	-586K	-192K
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-318.17M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	62K	n/a	n/a
Investing Cash Flow	-318.45M	-9K	-586K	-192K
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.6M	149K	160K
Financial Cash Flow	32.26M	334.03M	272.5M	31.7M
Net Cash Flow	-393.03M	259.27M	226.28M	-573K
Free Cash Flow	-107.11M	-74.82M	-46.21M	-32.27M
Adj. Free Cash Flow	-122.12M	-82.22M	-48.11M	-33.08M
Maintenance CapEx	-280K	-56K	-19K	-10K
Growth CapEx	n/a	-15K	-567K	-182K
Owner Earnings	-107.11M	-74.81M	-45.65M	-32.09M